View Product
> Fingertip textured
> Powder Free
> Not made with natural rubber latex
> Chemo drugs tested
> Ambidextrous
> Long Cuff
> Aqua blue colour
> Sterilised using gamma irradiation
Aegis, like an armour, offers superb hand barrier protection and chemical resistance. Our recommended sterile glove is thicker, with an extended cuff to suit situations which require greater protection.
| Reorder Code | Size |
|---|---|
| SNT26XS | X-Small (5.5) |
| SNT26SS | Small (6.0-6.5) |
| SNT26MM | Medium (7.0-7.5) |
| SNT26LL | Large (8.0-8.5) |
| SNT26XL | X-Large (9.0) |
| Glove Properties | Measurement (mm) |
|---|---|
| Length | ≥280 |
| Thickness at Palm (centre of Palm) | 0.09 ± 0.02 |
| Thickness at Finger (13mm ± 3mm from tip) | 0.14 ± 0.02 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥400 |
| Elongation after Isopropanol immersion (%) | ≥500 | N/A |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Packaging | |
|---|---|
| Configuration | 1 pair per pouch 50 pairs per box 4 boxes per carton |
| Regulatory Compliance | |
|---|---|
| Regulations | TGA - ARTG 203002 FDA 510(k) MDD 93/42/EEC REACH ROHS Directive 2002/95/EC EU 10/2011 EC 1935/2004 PPE 89/686/EEC |
| International Standards | |
|---|---|
| Standards | AS/NZS 4011.1:2014 ASTM D6319 ASTM D6978 EN 374 part 1, 2, 3 EN 455 part 1, 2, 3, 4 CEN/TS 14234 EN 1186 EN 13130 |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001:2015 ISO 13485:2003 EN ISO 13485:2012 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 104145A) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 15.1 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 30.8 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded an Aegis sterile nitrile glove at 15.1 minutes and 30.8 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
